IL6R and rheumatoid arthritis: Gene set enrichment analyses indicated that almost all these transcripts are downregulated by tocilizumab (anti-IL6R antibody) in the synovium in early RA, which indicates that they are, directly or indirectly, IL6-dependent (Fig. 1c).